Free Trial

Semler Scientific (SMLR) Competitors

Semler Scientific logo
$27.68 -1.43 (-4.91%)
Closing price 09/17/2025 04:00 PM Eastern
Extended Trading
$28.02 +0.34 (+1.23%)
As of 07:27 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SMLR vs. NVCR, SSII, CDRE, BLFS, ESTA, MDXG, PLSE, INMD, IRMD, and BBNX

Should you be buying Semler Scientific stock or one of its competitors? The main competitors of Semler Scientific include NovoCure (NVCR), SS Innovations International (SSII), Cadre (CDRE), BioLife Solutions (BLFS), Establishment Labs (ESTA), MiMedx Group (MDXG), Pulse Biosciences (PLSE), InMode (INMD), iRadimed (IRMD), and Beta Bionics (BBNX). These companies are all part of the "medical equipment" industry.

Semler Scientific vs. Its Competitors

NovoCure (NASDAQ:NVCR) and Semler Scientific (NASDAQ:SMLR) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, analyst recommendations, risk, valuation, dividends, media sentiment and institutional ownership.

In the previous week, Semler Scientific had 17 more articles in the media than NovoCure. MarketBeat recorded 25 mentions for Semler Scientific and 8 mentions for NovoCure. NovoCure's average media sentiment score of 0.93 beat Semler Scientific's score of 0.19 indicating that NovoCure is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
NovoCure
2 Very Positive mention(s)
4 Positive mention(s)
0 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Semler Scientific
1 Very Positive mention(s)
2 Positive mention(s)
22 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

NovoCure has a beta of 0.58, indicating that its stock price is 42% less volatile than the S&P 500. Comparatively, Semler Scientific has a beta of 1.39, indicating that its stock price is 39% more volatile than the S&P 500.

Semler Scientific has lower revenue, but higher earnings than NovoCure. NovoCure is trading at a lower price-to-earnings ratio than Semler Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NovoCure$605.22M2.34-$168.63M-$1.56-8.13
Semler Scientific$56.29M7.28$40.90M$2.4311.39

84.6% of NovoCure shares are held by institutional investors. Comparatively, 49.4% of Semler Scientific shares are held by institutional investors. 5.5% of NovoCure shares are held by company insiders. Comparatively, 16.4% of Semler Scientific shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

NovoCure presently has a consensus price target of $28.79, suggesting a potential upside of 126.84%. Semler Scientific has a consensus price target of $81.75, suggesting a potential upside of 195.34%. Given Semler Scientific's stronger consensus rating and higher possible upside, analysts plainly believe Semler Scientific is more favorable than NovoCure.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NovoCure
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.57
Semler Scientific
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.25

Semler Scientific has a net margin of 86.20% compared to NovoCure's net margin of -27.13%. Semler Scientific's return on equity of 43.84% beat NovoCure's return on equity.

Company Net Margins Return on Equity Return on Assets
NovoCure-27.13% -47.74% -13.79%
Semler Scientific 86.20%43.84%32.88%

Summary

Semler Scientific beats NovoCure on 13 of the 17 factors compared between the two stocks.

Get Semler Scientific News Delivered to You Automatically

Sign up to receive the latest news and ratings for SMLR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SMLR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SMLR vs. The Competition

MetricSemler ScientificMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$430.96M$6.78B$5.74B$10.30B
Dividend YieldN/A1.14%5.86%4.62%
P/E Ratio11.3926.5876.8526.52
Price / Sales7.28191.63453.0387.93
Price / Cash6.5021.7137.2260.63
Price / Book1.114.9413.686.31
Net Income$40.90M$178.07M$3.29B$271.37M
7 Day Performance-3.01%2.87%-0.75%0.57%
1 Month Performance-18.01%5.73%3.84%6.20%
1 Year Performance11.66%17.45%82.85%28.33%

Semler Scientific Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SMLR
Semler Scientific
2.9743 of 5 stars
$27.68
-4.9%
$81.75
+195.3%
+8.8%$430.96M$56.29M11.39120Gap Down
High Trading Volume
NVCR
NovoCure
4.2613 of 5 stars
$12.60
+2.6%
$28.79
+128.5%
-29.6%$1.37B$605.22M-8.081,488Positive News
Gap Up
SSII
SS Innovations International
N/A$6.14
-12.3%
N/AN/A$1.36B$20.65M0.004High Trading Volume
CDRE
Cadre
2.5445 of 5 stars
$31.83
-0.5%
$31.50
-1.0%
-9.7%$1.30B$567.56M33.862,284Positive News
BLFS
BioLife Solutions
2.708 of 5 stars
$26.22
-0.9%
$31.29
+19.3%
+9.1%$1.27B$93.47M-218.48440Positive News
ESTA
Establishment Labs
2.4194 of 5 stars
$38.24
-2.0%
$56.50
+47.8%
-10.2%$1.13B$166.02M-12.541,018Positive News
MDXG
MiMedx Group
3.4995 of 5 stars
$7.17
+0.4%
$12.00
+67.4%
+12.8%$1.06B$348.88M34.14870Positive News
PLSE
Pulse Biosciences
4.2445 of 5 stars
$15.04
-0.5%
$22.00
+46.3%
-20.0%$1.02B$700K-14.32140News Coverage
Positive News
Insider Trade
INMD
InMode
3.0445 of 5 stars
$15.28
+2.0%
$18.04
+18.1%
-14.0%$946.87M$401.56M6.19480Positive News
IRMD
iRadimed
4.8211 of 5 stars
$71.85
-0.2%
$72.00
+0.2%
+45.5%$915.36M$73.24M44.35110Positive News
Short Interest ↓
BBNX
Beta Bionics
1.0631 of 5 stars
$23.13
+14.5%
$22.56
-2.5%
N/A$878.10M$65.12M0.00294High Trading Volume

Related Companies and Tools


This page (NASDAQ:SMLR) was last updated on 9/18/2025 by MarketBeat.com Staff
From Our Partners